LynceiSign in
Demo version of Lyncei. People, studies and DOIs are fictional; anyone can sign in to the demo accounts.
All questions
?

Do SGLT2 inhibitors improve outcomes in heart failure with preserved ejection fraction?

2 following
Post to this question

Where the evidence stands

1 post linked · 1 with a completed review · 2 contributions in discussion.

Dr. Elena CastroCardiology
22h
Video explainer

Early results from a multicenter trial on SGLT2 inhibitors in heart failure with preserved ejection fraction

The trial reports a reduction in the composite primary outcome. Here's what was measured, who was included, and the limits to keep in mind before changing practice.

[Demo] SGLT2 inhibition in heart failure with preserved ejection fraction: a multicenter trialDemo Journal of Cardiology · 2026doi:10.5555/demo.hfpef.2026
Do SGLT2 inhibitors improve outcomes in heart failure with preserved ejection fraction?
Human expert review completed2 reviews
602
Rigor
Expert-reviewed
Qualified reviewers assessed the methods and statistics. This does not mean the result is settled. Reach (likes, shares) never changes this label.